0.2911
0 (-1.36%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.33 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 0.22 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -132.09% | ||
| ROE | 139.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | -348.95% | ||
| PM (TTM) | -346.48% | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | -0.07 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.54 | ||
| Quick Ratio | 0.5 | ||
| Altman-Z | -8.31 |
ChartMill assigns a fundamental rating of 2 / 10 to INSY.
ChartMill assigns a valuation rating of 2 / 10 to Insys Therapeutics Inc. (INSY). This can be considered as Overvalued.
Insys Therapeutics Inc. (INSY) has a profitability rating of 1 / 10.
The financial health rating of Insys Therapeutics Inc. (INSY) is 1 / 10.
The dividend rating of Insys Therapeutics Inc. (INSY) is 0 / 10 and the dividend payout ratio is 0%.